Differential cell cycle checkpoint response in normal human keratinocytes and fibroblasts

Cell Growth and Differentiation

Volumn 9, Issue 7, 1998, Pages 535-543

  Flatt, Patricia M ^a   Price, James O ^b,d   Shaw, Amy ^c   Pietenpol, Jennifer A ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL TYPE; CONTROLLED STUDY; FIBROBLAST; GAMMA IRRADIATION; GENE MUTATION; GENOTOXICITY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL;

CDC2-CDC28 KINASES; CELL CYCLE; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; DNA DAMAGE; FIBROBLASTS; G1 PHASE; G2 PHASE; GAMMA RAYS; HUMANS; KERATINOCYTES; MUTAGENS; PROTEIN-SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031843408     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Hartwell, L. H., and Kastan, M. B. Cell cycle control and cancer. Science (Washington DC), 266: 1821-1828, 1994.
2. 1 to S-phase transition. Annu. Rev. Cell Biol., 8: 529-561, 1992.
3. Morgan, D. O. Principles of CDK regulation. Nature (Lond.), 374: 131-134, 1995.
4. 1 phase progression: cycling on cue. Cell, 79: 551-555, 1994.
5. Hartwell, L. H., and Weinert, T. A. Checkpoints. Controls that ensure the order of cell cycle events. Science (Washington DC), 246: 629-634, 1989.
6. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., and Craig, R. W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res., 51: 6304-6311, 1991.
7. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
8. Lu, X., and Lane, D. P. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes. Cell, 75: 765-778, 1993.
9. Macleod, K. F., Sherry, N., Hannon, G., Beach, D., Tokino, T., Kinzler, K., Vogelstein, B., and Jacks, T. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev., 9: 935-944, 1995.
10. 1 arrest and apoptosis. Cancer Res., 54: 1169-1174, 1994.
11. Chen, C-Y., Oliner, J. D., Zhan, Q., Fornace, A. J., Jr, Vogelstein, B., and Kastan, M. B. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway. Proc. Natl. Acad. Sci. USA, 91: 2684-2688, 1994.
12. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. J., Jr. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell, 71: 587-597, 1992.
13. 1 checkpoint control. Cell, 82: 675-684, 1995.
14. Brugarolas, J., Chandrasekaran, C., Gordon, J. I., Beach, D., Jacks, T., and Hannon, G. J. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature (Lond.), 377: 552-557, 1995.
15. 1 arrest in human cancer cells. Cancer Res., 55: 5187-5190, 1995.
16. Yonish-Rouach, E., Resnitzky, D., Lotem, J., Sachs, L., Kimchi, A., and Oren, M. Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature (Lond.), 352: 345-347, 1991.
17. Shaw, P., Bovey, R., Tardy, S., Sahli, R., Sordat, B., and Costa, J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc. Natl. Acad. Sci. USA, 89: 4495-4499, 1992.
18. Debbas, M., and White, E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev., 7: 546-554, 1993.
19. Lowe, S. W., Schmitt, E. M., Smith, S. W., Osborne, B. A., and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
20. 1 cell cycle checkpoints and mediates reversible growth arrest in human fibroblasts. Proc. Natl. Acad. Sci. USA, 92: 8493-8497, 1995.
21. Little, J. B. Delayed initiation of DNA synthesis in irradiated human diploid cells. Nature (Lond.), 278: 1064-1065, 1968.
22. Little, J. B., and Nagasawa, H. Effect of confluent holding on potentially lethal damage repair, cell cycle progression, and chromosomal aberrations in human normal and ataxia-telangiectasia fibroblasts. Radiat. Res., 101: 81-93, 1985.
23. Bates, S., and Vousden, K. H. p53 in signaling checkpoint arrest or apoptosis. Curr. Opin. Genet. Dev., 6: 12-18, 1996.
24. 1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev., 8: 2540-2551, 1994.
25. 1 arrest in two closely related human lymphoblast cell lines that differ in p53 status. J. Biol. Chem., 270:11033-11036,1995.
26. 1 phase arrest and p53 function in human tumor cells. Cancer Res., 55: 1842-1846, 1995.
27. 1 arrest in established human tumor cell lines. Oncogene, 11: 1885-1892, 1995.
28. Ji, C., Marnett, L. J., and Pietenpol, J. A. Cell cycle re-entry following chemically-induced cell cycle synchronization leads to elevated levels of p53 and p21 protein levels. Oncogene, 15: 2749-2753, 1997.
29. cdc2-cyclin B complex by the human WEE1 tyrosine kinase. Science (Washington DC), 257: 1955-1957, 1992.
30. McGowan, C. H., and Russell, P. Human wee1 kinase inhibits cell division by phosphorylating p34cdc2 exclusively on Tyr 15. EMBO J., 12: 75-85, 1993.
31. Liu, F., Stanton, J. J., Wu, Z., and Piwnica-Worms, H. The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex. Mol. Cell. Biol., 17: 571-583, 1997.
32. Roberts, J. M., Koff, A., Polyak, K., Firpo, E., Collins, S., Ohtsubo, M., and Massagué, J. Cyclins, Cdks, and cyclin kinase inhibitors. Cold Spring Harbor Symp. Quant. Biol., 59: 31-38, 1994.
33. 1-to-S phase transition. Mol. Cell. Biol., 15: 2612-2624, 1995.
34. 1-S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol., 14: 1669-1679, 1994.
35. Nurse, P. Universal control mechanism regulating onset of M-phase. Nature (Lond.), 344: 503-508, 1990.
36. Davis, F. M., Tsao, T. Y., Fowler, S. K., and Rao, P. N. Monoclonal antibodies to mitotic cells. Proc. Natl. Acad. Sci. USA, 80: 2926-2930, 1983.
37. cdc2 and apoptosis. Science (Washington DC), 269: 106-107, 1995.
38. cdc2 activation required for apoptosis. Science (Washington DC), 263: 1143-1145, 1994.
39. Morgan, S. E., and Kastan, M. B. p53, and ATM. Cell cycle, cell death, and cancer. Adv. Cancer Res., 71: 1-25, 1997.
40. Gadbois, D. M., and Lehnert, B. E. Cell cycle response to DNA damage differs in bronchial epithelial cells and lung fibroblasts. Cancer Res., 57: 3174-3179, 1997.
41. Abrahams, P. J., Scheuten, R., Van Laar, T., Houweling, A., Terleth, C., and Van der Eb, A. J. Different regulation of p53 stability in UV-irradiated normal and DNA repair deficient human cells. Mutat. Res., 336: 169-180, 1995.
42. Tishler, R. B., Calderwood, S. K., Coleman, N., and Price, B. D. Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA-damaging agents. Cancer Res., 53: 2212-2216, 1993.
43. Weinberg, W. C., Azzoli, C. G., Chapman, K., Levine, A. J., and Yuspa, S. H. p53-mediated transcriptional activity increases in differentiating epidermal keratinocytes in association with decreased p53 protein. Oncogene, 10: 2271-2279, 1995.
44. Kaufmann, W. K. Cell cycle checkpoints and DNA repair preserve the stability of the human genome. Cancer Metastasis Rev., 14: 31-41, 1995.
45. Fornace, A. J., Lechner, J. F., Grafstrom, R. C., and Harris, C. C. DNA repair in human bronchial epithelial cells. Carcinogenesis (Lond.), 4:1373-1377, 1982.
46. Nelson, W. G., and Kastan, M. B. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol., 14: 1815-1823, 1994.
47. 2-M delay and cellular radiosensitivity. Int. J. Radiat. Biol., 66: 373-379, 1994.
48. 2-phase cell cycle checkpoint control is associated with increased frequencies of unrejoined chromosome breaks in human tumor cells. Radiat. Res., 146: 139-143, 1996.
49. Pietenpol, J. A., Tokino, T., El-Deiry, W. S., Kinzler, K. W., and Vogelstein, B. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl. Acad. Sci. USA, 97: 1998-2002, 1994.
50. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAF1, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
51. Murnane, J. P. Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective. Cancer Metastasis Rev., 14: 17-29, 1995.
52. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
53. 1 cyclin-dependent kinases. Cell, 75: 805-816, 1993.
54. Blasina, A., Paegle, E. S., and McGowan, C. H. The role of inhibitory phosphorylation of CDC2 following DNA replication block and radiation-induced damage in human cells. Mol. Biol. Cell, 8: 1013-1023, 1997.
55. Poon, R. Y. C., Chau, M. S., Yamashita, K., and Hunter, T. The role of Cdc2 feedback loop control in the DNA damage checkpoint in mammalian cells. Cancer Res., 57: 5168-5178, 1997.
56. Furnari, B., Rhind, N., and Russell, P. Cdc25C mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science (Washington DC), 277: 1495-1497, 1997.
57. Sanchez, Y., Wong, S., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., and Elledge, S. J. Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25C. Science (Washington DC), 277: 1497-1501, 1997.
58. 2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25c on serine-216. Science (Washington DC), 277: 1501-1505, 1997.
59. 2-M progression. Mol. Cell, 1: 3-11, 1998.
60. Nurse, P. Checkpoint pathways come of age. Cell, 97: 865-867, 1997.
61. Brash, D. E. Sunlight and the onset of skin cancer. Trends Genet., 13: 410-414, 1997.
62. 1 kinase activity for cdk6, a novel cyclin D partner. Mol. Cell. Biol., 74: 2077-2086, 1994.